177 related articles for article (PubMed ID: 19229987)
1. Enzyme replacement therapy for mild patients with Gaucher disease.
Zimran A; Ilan Y; Elstein D
Am J Hematol; 2009 Apr; 84(4):202-4. PubMed ID: 19229987
[No Abstract] [Full Text] [Related]
2. Gaucher disease: resetting the clinical and scientific agenda.
Mistry PK; Weinreb NJ; Brady RO; Grabowski GA
Am J Hematol; 2009 Apr; 84(4):205-7. PubMed ID: 19296473
[No Abstract] [Full Text] [Related]
3. Enzyme, substrate, and myeloma in Gaucher disease.
Hughes DA
Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
[No Abstract] [Full Text] [Related]
4. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.
Holubar J; Bres V; Costes-Martineau V; Pers YM
Blood Cells Mol Dis; 2018 Feb; 68():112-114. PubMed ID: 28559130
[No Abstract] [Full Text] [Related]
5. Competing for the treasure in exceptions.
Cox TM
Am J Hematol; 2013 Mar; 88(3):163-5. PubMed ID: 23400870
[No Abstract] [Full Text] [Related]
6. [Gaucher disease].
Eto Y
Nihon Rinsho; 2001 Mar; 59 Suppl 3():317-21. PubMed ID: 11347084
[No Abstract] [Full Text] [Related]
7. Early access experience with VPRIV(®): recommendations for 'core data' collection.
Hughes DA; Al-Sayed M; Belmatoug N; Bodamer O; Böttcher T; Cappellini M; Cohen IJ; Eagleton T; Elstein D; Giraldo P; Jones S; Kaplinsky C; Lund A; Machaczka M; Mengel E; Pastores GM; Rosenbaum H; Sjo M; Tiling N; Tsaftaridis P; Zimran A; Weinreb N
Blood Cells Mol Dis; 2011 Aug; 47(2):140-2. PubMed ID: 21146428
[No Abstract] [Full Text] [Related]
8. Using the International Gaucher Disease Registry data: can we devise a virtuous circle for treated patients?
Elstein D; Zimran A
Am J Hematol; 2008 Dec; 83(12):887-9. PubMed ID: 18980272
[No Abstract] [Full Text] [Related]
9. Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.
Aviner S; Garty BZ; Rachmel A; Baris HN; Sidransky E; Shuffer A; Attias J; Yaniv Y; Cohen IJ
Blood Cells Mol Dis; 2009; 43(3):294-7. PubMed ID: 19734074
[TBL] [Abstract][Full Text] [Related]
10. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Hachulla E; Javier RM
Rev Med Interne; 2007 Oct; 28 Suppl 2():S180-2. PubMed ID: 18228685
[No Abstract] [Full Text] [Related]
11. Alglucerase (Ceredase).
Wiltink EH; Hollak CE
Pharm World Sci; 1996 Jan; 18(1):16-9. PubMed ID: 8861826
[No Abstract] [Full Text] [Related]
12. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
Taddei TH; Kacena KA; Yang M; Yang R; Malhotra A; Boxer M; Aleck KA; Rennert G; Pastores GM; Mistry PK
Am J Hematol; 2009 Apr; 84(4):208-14. PubMed ID: 19260119
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher.
Belmatoug N; Launay O; Carbon C
Lancet; 1998 Jul; 352(9123):240. PubMed ID: 9683246
[No Abstract] [Full Text] [Related]
14. Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy--unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease.
Migita M; Hamada H; Fujimura J; Watanabe A; Shimada T; Fukunaga Y
Eur J Pediatr; 2003 Jul; 162(7-8):524-525. PubMed ID: 12845529
[No Abstract] [Full Text] [Related]
15. The metabolism of glucocerebrosides - From 1965 to the present.
Futerman AH; Platt FM
Mol Genet Metab; 2017; 120(1-2):22-26. PubMed ID: 27955980
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
17. Response of Gaucher bone disease to enzyme replacement therapy.
Poll LW; Maas M; Terk MR; Roca-Espiau M; Bembi B; Ciana G; Weinreb NJ
Br J Radiol; 2002; 75 Suppl 1():A25-36. PubMed ID: 12036830
[TBL] [Abstract][Full Text] [Related]
18. Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.
Tsuboi K; Iida S; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Komatsu H; Banno S; Wakita A; Nitta M; Ueda R
Int J Hematol; 2001 Apr; 73(3):356-62. PubMed ID: 11345203
[TBL] [Abstract][Full Text] [Related]
19. IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report.
Martinez-Redondo C; Ortuño FJ; Lozano ML; Jerez A; del Mar Osma M; Giraldo P; Vicente V
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S265-7. PubMed ID: 19562501
[TBL] [Abstract][Full Text] [Related]
20. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
